Clinical Trials Browser

Interventional × Lymphoma × SNX-5422 × Clear all

NCT00644072 2017-07-02

SNX-5422 to Treat Solid Tumor Cancers and Lymphomas

Phase 1 Completed

Lymphoma, Neoplasms